TELUS engages TD Securities and Jefferies as financial advisors to support TELUS Health partnership and monetisation strategy

Core Insights - TELUS Corporation is engaging TD Securities Inc. and Jefferies Securities, Inc. as financial advisors to strategize the monetization of its TELUS Health business, which serves over 160 million lives globally and has generated $1.5 billion in operating revenue year-to-date as of Q3 2025 [1][2] Group 1: TELUS Health Business Overview - TELUS Health operates in over 200 countries and territories, generating an EBITDA of $258 million and cash flow of $99 million as of Q3 2025 [1] - The company views TELUS Health as a world-class digital asset with significant growth potential, particularly in AI products and international expansion [2] Group 2: Strategic Partnerships and Monetization - The monetization strategy aims to identify a strategic partner to enhance value creation by adding complementary skills and customer reach [2] - TELUS Health is considered a key near-term monetization opportunity that aligns with TELUS' deleveraging targets, aiming for a net debt to adjusted EBITDA ratio of approximately 3.4 times in 2025, reducing to around 3.3 times by the end of 2026 [2] Group 3: Financial Performance and Future Outlook - TELUS is targeting a minimum 10% compounded annual growth rate in free cash flow through 2028, supported by a strong operational and financial performance [2] - The engagement of financial advisors is part of a disciplined capital allocation framework that has consistently defined TELUS' approach to value creation [2]